These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20576034

  • 1. HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems.
    Fujiwara T, Snada M, Kofuji T, Yoshikawa T, Akagawa K.
    Eur J Neurosci; 2010 Jul; 32(1):99-107. PubMed ID: 20576034
    [Abstract] [Full Text] [Related]

  • 2. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

  • 3. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP, Bouvard M, Stinus L.
    Neuropsychopharmacology; 2001 Apr 04; 24(4):379-90. PubMed ID: 11182533
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.
    Mato S, Aso E, Castro E, Martín M, Valverde O, Maldonado R, Pazos A.
    J Neurochem; 2007 Dec 04; 103(5):2111-20. PubMed ID: 17944876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.
    J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

  • 10. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G, De Deurwaerdère P, Caccia S, Umberto Spampinato.
    Neuropharmacology; 2000 Apr 03; 39(6):1053-63. PubMed ID: 10727716
    [Abstract] [Full Text] [Related]

  • 11. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY.
    J Neurochem; 2001 Mar 03; 76(5):1521-31. PubMed ID: 11238736
    [Abstract] [Full Text] [Related]

  • 12. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA, Hen R, Blendy JA, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 03; 298(3):1092-100. PubMed ID: 11504806
    [Abstract] [Full Text] [Related]

  • 13. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 03; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 14. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 15. Dysfunction of the hypothalamic-pituitary-adrenal axis in STX1A knockout mice.
    Fujiwara T, Kofuji T, Akagawa K.
    J Neuroendocrinol; 2011 Dec 11; 23(12):1222-30. PubMed ID: 21910766
    [Abstract] [Full Text] [Related]

  • 16. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.
    Korff S, Stein DJ, Harvey BH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):348-55. PubMed ID: 17888556
    [Abstract] [Full Text] [Related]

  • 17. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A, Artaiz I, Labeaga L, Lucero ML, Orjales A.
    Neuropharmacology; 2007 Mar 15; 52(3):975-84. PubMed ID: 17141811
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C, Yu H, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb 15; 363(2):222-32. PubMed ID: 11218075
    [Abstract] [Full Text] [Related]

  • 19. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD, Raap DK, Battaglia G, Muma NA, Garcia F, DonCarlos LL.
    Neuropharmacology; 2002 Jul 15; 43(1):45-54. PubMed ID: 12213258
    [Abstract] [Full Text] [Related]

  • 20. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F.
    Psychopharmacology (Berl); 2007 Apr 15; 191(3):745-58. PubMed ID: 17265076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.